Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q4 2024 Earnings Call Transcript February 19, 2025
Ionis Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.66, expectations were $-1.09.
Operator: Good morning, and welcome to Ionis Pharmaceuticals, Inc.’s Fourth Quarter and Full Year 2024 Financial Results Conference Call. As a reminder, this call is being recorded. At this time, I would like to turn the call over to Wade Walke, Senior Vice President of Investor Relations to...
